Diagnosticos da America S.A. (DASA3) Price & Analysis

― Followers

DASA3 Stock Chart & Stats

$2.61

-$0.03(-1.14%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range$1.22 - $4.77

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

R$3.30B

Enterprise Value$10.13K

Total Cash (Recent Filing)R$1.71B

Total Debt (Recent Filing)R$8.14B

Price to Earnings (P/E)―

Beta1.45

Next Earnings

Aug 13, 2026

EPS Estimate

-0.26

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.82

Shares Outstanding1,255,007,100

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio1.18

Price to Book (P/B)0.83

Price to Sales (P/S)0.51

P/FCF Ratio-17.44

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.12

Revenue Forecast (FY)R$9.29B

DASA3 FAQ

What was Diagnosticos da America S.A.’s price range in the past 12 months?

Diagnosticos da America S.A. lowest stock price was $1.22 and its highest was $4.77 in the past 12 months.

What is Diagnosticos da America S.A.’s market cap?

Diagnosticos da America S.A.’s market cap is R$3.30B.

When is Diagnosticos da America S.A.’s upcoming earnings report date?

Diagnosticos da America S.A.’s upcoming earnings report date is Aug 13, 2026 which is in 12 days.

How were Diagnosticos da America S.A.’s earnings last quarter?

Diagnosticos da America S.A. released its earnings results on May 12, 2026. The company reported -$0.004 earnings per share for the quarter, beating the consensus estimate of -$0.76 by $0.756.

Is Diagnosticos da America S.A. overvalued?

According to Wall Street analysts Diagnosticos da America S.A.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Diagnosticos da America S.A. pay dividends?

Diagnosticos da America S.A. does not currently pay dividends.

What is Diagnosticos da America S.A.’s EPS estimate?

Diagnosticos da America S.A.’s EPS estimate is -0.26.

How many shares outstanding does Diagnosticos da America S.A. have?

Diagnosticos da America S.A. has 1,255,007,100 shares outstanding.

What happened to Diagnosticos da America S.A.’s price movement after its last earnings report?

Diagnosticos da America S.A. reported an EPS of -$0.004 in its last earnings report, beating expectations of -$0.76. Following the earnings report the stock price went up 3.503%.

Which hedge fund is a major shareholder of Diagnosticos da America S.A.?

Currently, no hedge funds are holding shares in BR:DASA3

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Diagnosticos da America S.A.

Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.